Your browser doesn't support javascript.
loading
Lack of benefit of 3-month intensification with enfuvirtide plus optimized background regimen (OBR) versus OBR alone in patients with multiple therapeutic failures: the INNOVE study.
Morand-Joubert, Laurence; Ghosn, Jade; Delaugerre, Constance; Giffo, Boniface; Solas, Caroline; Samri, Assia; Pinta, Alexandrina; Triglia, Aurore; Raffi, François.
Affiliation
  • Morand-Joubert L; Laboratory of Virology, AP-HP, CHU Saint-Antoine, UPMC University Paris 06, INSERM U943, Paris, France.
J Med Virol ; 84(11): 1710-8, 2012 Nov.
Article in En | MEDLINE | ID: mdl-22997073
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / HIV Envelope Protein gp41 / HIV Infections / Salvage Therapy / Anti-HIV Agents / Antiretroviral Therapy, Highly Active Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Med Virol Year: 2012 Type: Article Affiliation country: France
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Peptide Fragments / HIV Envelope Protein gp41 / HIV Infections / Salvage Therapy / Anti-HIV Agents / Antiretroviral Therapy, Highly Active Type of study: Clinical_trials / Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Med Virol Year: 2012 Type: Article Affiliation country: France